Burden of atopic dermatitis in Canada

International Journal of Dermatology

Volumn 45, Issue 1, 2006, Pages 31-36

  Barbeau, Martin ^a   Lalonde, Hélène ^a  

^a Novartis Pharmaceuticals Canada Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NON PRESCRIPTION DRUG; TACROLIMUS; DERMATOLOGICAL AGENT;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CANADA; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DATA ANALYSIS; DERMATOLOGY; DISEASE SEVERITY; DRUG COST; EMPLOYER; EXPERIENCE; FAMILY; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH PRACTITIONER; HEALTH SURVEY; HOSPITAL BILLING; HOUSEHOLD; HUMAN; INCOME; INFANT; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL SPECIALIST; PRESCRIPTION; PREVALENCE; QUANTITATIVE ANALYSIS; SLEEP DISORDER; SOCIETY; AGE DISTRIBUTION; COMPARATIVE STUDY; ECONOMICS; FEMALE; HOSPITALIZATION; INCIDENCE; MALE; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; ONTARIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 33646001744     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02345.x     Document Type: Article

References (24)

1. Knoell KA, Greer KE. Atopic dermatitis. Pediatr Rev 1999; 20: 46-51.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160.
3. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103: 125-138.
4. Schultz-Larsen F. Atopic dermatitis: A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993; 28: 719-723.
5. Laughter D, Istvan JA, Tofte SJ, et al. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000; 43: 649-655.
6. McAlister RO, Tofte SJ, Doyle JJ, et al. Patient and physician perspectives vary on atopic dermatitis. Cutis 2002; 69: 461-466.
7. Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41: 151-158.
8. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992; 17: 385-391.
9. Nicol NH. Managing atopic dermatitis in children and adults. Nurse Pract 2000; 25: 58-81.
10. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46: 228-241.
11. Lapidus CS, Schwarz DF, Honig PJ. Atopic dermatitis in children: Who cares? Who pays? J Am Acad Dermatol 1993; 28: 699-703.
12. Bank of Canada. Exchange Rate Look-Up. http://www.bankofcanada.ca/en/ exchange-convert.htm, accessed July 30, 2003.
13. Emerson RM, Williams HC, Allen BR. What is the cost of atopic dermatitis in preschool children? Br J Dermatol 2001; 144: 514-522.
14. Herd RM, Tidman MJ, Prescott RJ, et al. The cost of atopic eczema. Br J Dermatol 1996; 135: 20-23.
15. Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361-370.
16. Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, et al. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856-860.
17. Bartlet LB, Westbroek R, White JE. Sleep patterns in children with atopic eczema. Acta Derm Venereol 1997; 77: 446-448.
18. Paller AS, McAlister RO, Doyle JJ, et al. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila) 2002; 41: 323-332.
19. Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: Its impact on the family and financial cost. Arch Dis Child 1997; 76: 159-162.
20. Nagaraja Kanwar AJ, Dhar S, et al. Frequency and significance of minor clinical features in various age-related subgroups of atopic dermatitis in children. Pediatr Dermatol 1996; 13: 10-13.
21. Ontario Ministry of Health. Schedule of Benefits: Physician Services under the Health Insurance Act 2001.
22. Statistics Canada. Population of Canada by sex and age group, 2003. http://www.statcan.ca, accessed July 30, 2003.
23. Gieler U, Hohmann M, Niemeier V, et al. Cost evaluation in atopic eczema. J Dermatolog Treat 1999; 10: S15-S20.
24. Drummond MF, O'Brien B, Stoddart GL, et al. Cost-benefit analysis. In: Methods for Economic Evaluation of Health Care Programmes, 2nd edn. New York, NY: Oxford University Press, 1997: 205-231.